ABBV-744

Item number	Size	Delivery time	Price
TGM-T4697-1mg	1 mg	7 - 10 business days*	40.00€
TGM-T4697-2mg	2 mg	7 - 10 business days*	55.00€
TGM-T4697-1mL	1 ml	7 - 10 business days*	97.00€
TGM-T4697-5mg	5 mg	7 - 10 business days*	97.00€
TGM-T4697-10mg	10 mg	7 - 10 business days*	152.00€
TGM-T4697-25mg	25 mg	7 - 10 business days*	314.00€
TGM-T4697-50mg	50 mg	7 - 10 business days*	453.00€
TGM-T4697-100mg	100 mg	7 - 10 business days*	554.00€
TGM-T4697-200mg	200 mg	7 - 10 business days*	798.00€

If you have any questions, please use our Contact Form.
You can also order by e-mail: info@biomol.com
Larger quantity required? Request bulk

Description: ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is... more

Close menu

Product information "ABBV-744"

Description: ABBV-744 is a BDII-selective BET bromodomain inhibitor that inhibits BRD2/3/4. It is used in the research on inflammatory diseases, cancer, and AIDS. Target: Epigenetic Reader Domain, HIV Protease. Smiles: CCNC(=O)c1cc2c(cn(C)c(=O)c2[nH]1)-c1cc(ccc1Oc1c(C)cc(F)cc1C)C(C)(C)O. References: Emily J. Faivre, et al. First-in-class, highly BDII-selective BET family inhibitor ABBV-744 displays potent anti-tumor activity in androgen receptor positive prostate cancer models and an improved tolerability profile. Cancer Res. 2018, 78(13 Suppl):Abstract nr 4960.

Keywords:	ABBV744
Supplier:	TargetMol
Supplier-Nr:	T4697

Properties

Application:	BD2 bromodomain inhibitor
MW:	491.55 D
Formula:	C28H30FN3O4

Database Information

CAS :	2138861-99-9\| Matching products
KEGG ID :	K11724 \| Matching products

Handling & Safety

Storage:	-20°C
Shipping:	+4°C (International: +4°C)

Caution
Our products are for laboratory research use only: Not for administration to humans!

Information about the product reference will follow. more

Close menu

You will get a certificate here

Go back

Read, write and discuss reviews... more

Close menu

Customer review for "ABBV-744"

Write a review